HSBC Holdings
PRAX icon

HSBC Holdings’s Praxis Precision Medicines PRAX Stock Holding History

HSBC Holdings’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
942
-692
-42% -$219K ﹤0.01% 2476
2026
Q1 		$518K Buy
1,634
+809
+98% +$250K ﹤0.01% 2204
2025
Q4 		$244K Sell
825
-10,347
-93% -$1.93M ﹤0.01% 2604
2025
Q3 		$595K Buy
+11,172
New +$542K ﹤0.01% 2017

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

HSBC Holdings's PRAX Position: Q2 2026 in Review

HSBC Holdings reduced its Praxis Precision Medicines (PRAX) stake by 42% in Q2 2026, selling an estimated $219K and leaving 942 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

HSBC Holdings first reported a position in PRAX in Q3 2025 and has held it in 4 quarters since. The position peaked at $595K in Q3 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • HSBC Holdings held 942 shares of Praxis Precision Medicines worth $325K as of Q2 2026.
  • HSBC Holdings sold 692 Praxis Precision Medicines shares in Q2 2026, an estimated $219K.
  • Praxis Precision Medicines made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2476 holding.
  • HSBC Holdings first reported a position in Praxis Precision Medicines in Q3 2025 and has held it in 4 quarters since.
  • HSBC Holdings's Praxis Precision Medicines position peaked at $595K in Q3 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.